ReNeuron Gains UK Regulatory Approval to Start Ground-breaking Clinical Trial with Stem Cell Therapy for Stroke
ReNeuron Group plc recently announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency to commence a first-in-man clinical trial for the treatment of patients who have been left disabled by an ischaemic stroke, the most common form of the condition.

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Osiris Therapeutics, Inc. announced recently that it has held a successful pre-Biologics License Application meeting for Prochymal used in the treatment of graft-versus-host disease.

Novel Cell Lines Propel the Search for Safer Stem Cell Induction
Whitehead Institute researchers have reliably produced mice and mouse cell lines with identical configurations of the specific factors needed to reprogram adult cells to an embryonic-stem-cell-like state.

International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
International Stem Cell Corporation has created layered human tissue from its unique parthenogenetic stem cells and transplanted this tissue into animals in pre-clinical trials to establish a potential new treatment for human retinal diseases.

A Gene Expression Signature Shared by Human Mature Oocytes and Embryonic Stem Cells
Comparison of the transcriptome of human mature MII oocytes and embryonic stem cells may highlight genes that are involved in pluripotency initiation.

The Reversal of Hyperglycaemia in Diabetic Mice Using PLGA Scaffolds Seeded with Islet-like Cells Derived from Human Embryonic Stem Cells
Here, the researchers demonstrated a five-stage protocol with adding exendin-4 instead of nicotinamide finally could generate islet-like cells from human embryonic stem cells.

Reptin52 Expression During in vitro Neural Differentiation of Human Embryonic Stem Cells
The researchers analyzed hESC and hESC-derived neural stem cell nuclear extracts revealing an increased expression of Reptin52 in neurosphere nuclei.

Cardiomyogenic Differentiation of Embryoid Bodies is Promoted by Rotary Orbital Suspension Culture
The objective of this study was to determine if rotary orbital suspension culture, which produces embryoid bodies resembling hanging drops, was capable of enhancing cardiomyogenic differentiation compared to static suspension culture.

Cellartis, WARF Sign License Agreement for Human Embryonic Stem Cells
Cellartis AB and the Wisconsin Alumni Research Foundation announced recently that they have signed a license for hES patents that enables Cellartis to commercialize undifferentiated hES cell products in the U.S.

VistaGen and Capsant Sign Strategic Stem Cell Technology Commercialization Agreement
VistaGen and Capsant have signed a strategic commercialization agreement under which the companies will combine their leading-edge stem cell biology and 3D cell culture platforms, respectively, to advance their mutual business interests worldwide.

California Panel Warns Stem Cell Agency Board Member
A California ethics panel has chided a member of the state's stem cell agency board for trying to influence funding for a La Jolla research institute he leads.

BioE Receives FDA 510(K) Clearance for Cord Blood Processing System
BioE Inc. announced recently it received 510(k) clearance from the U.S. Food and Drug Administration for its PrepaCyte-CB Processing System for umbilical cord blood.

VIDEO: White House Stem Cell Shift Expected
A major shift in White House policy on stem cell research is expected when Barack Obama takes office.

Japanese Ministry Set to Boost Stem Cell Patent Support
The Education, Science and Technology Ministry has decided to expand support for universities and research institutions bidding to patent technologies and ideas used in their studies on induced pluripotent stem cells, officials said.

MPs to Investigate Stem Cell Funding Row
The two research councils that have turned down requests to fund stem cell studies using human-animal "hybrid" embryos are to be questioned by MPs on both sides of the House of Commons to explain why they have refused to issue the grants.